• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
In vitro thymidine labelling of human pulmonary neoplasms.人肺肿瘤的体外胸苷标记
Br J Cancer. 1983 Feb;47(2):245-52. doi: 10.1038/bjc.1983.32.
2
Actual growth rate and tumour cell proliferation in human pulmonary neoplasms.人类肺部肿瘤的实际生长速率与肿瘤细胞增殖
Br J Cancer. 1984 Sep;50(3):343-9. doi: 10.1038/bjc.1984.181.
3
A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma.人类支气管源性癌患者生存率与肿瘤生长动力学的比较。
Br J Cancer. 1988 Oct;58(4):419-22. doi: 10.1038/bjc.1988.233.
4
Tritiated thymidine labelling in vitro of human cancer of the breast: counting error and sampling error.人乳腺癌的体外氚标记胸腺嘧啶核苷:计数误差与抽样误差
Eur J Cancer Clin Oncol. 1986 Jul;22(7):781-5. doi: 10.1016/0277-5379(86)90363-9.
5
Studies on lung tumours. IV. Correlation between [3H]thymidine labelling of lung and liver cells and tumour formation in GRS/A and C3Hf/A male mice following administration of dimethylnitrosamine.肺癌研究。IV. 给予二甲基亚硝胺后,GRS/A和C3Hf/A雄性小鼠肺和肝细胞的[3H]胸腺嘧啶核苷标记与肿瘤形成之间的相关性。
Chem Biol Interact. 1979 Mar;24(3):299-316. doi: 10.1016/0009-2797(79)90079-6.
6
The validity of the labelling index in tumour studies.肿瘤研究中标记指数的有效性。
Br J Cancer. 1985 Jan;51(1):15-21. doi: 10.1038/bjc.1985.3.
7
[The relationship between the doubling time of human lung tumor volume and the labelling index].[人类肺肿瘤体积倍增时间与标记指数之间的关系]
Biull Eksp Biol Med. 1976 Jan;81(1):59-61.
8
3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.作为肿瘤生长异质性标志物的3H-胸腺嘧啶核苷标记指数(TLI):在人类实体癌中的评估
Cell Prolif. 1997 Mar-Apr;30(3-4):117-26. doi: 10.1046/j.1365-2184.1997.00074.x.
9
In vitro thymidine labelling index in primary operable breast cancer.
Eur J Surg Oncol. 1986 Mar;12(1):53-7.
10
Labelling patterns of carcinomas of the cervix and their precancerous stages after 3H-thymidine incorporation.3H-胸腺嘧啶核苷掺入后宫颈癌及其癌前阶段的标记模式
Acta Histochem Suppl. 1983;27:111-5.

引用本文的文献

1
Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms.人肺肿瘤中的细胞增殖、细胞丢失以及bcl-2和p53的表达
Br J Cancer. 1997;75(4):545-7. doi: 10.1038/bjc.1997.95.
2
P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer.可手术的局部晚期非小细胞肺癌中的P53表达、DNA倍体和S期细胞分数
Br J Cancer. 1996 Apr;73(7):914-9. doi: 10.1038/bjc.1996.163.
3
Actual growth rate and tumour cell proliferation in human pulmonary neoplasms.人类肺部肿瘤的实际生长速率与肿瘤细胞增殖
Br J Cancer. 1984 Sep;50(3):343-9. doi: 10.1038/bjc.1984.181.
4
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.自然和人工月经周期中人类乳腺的增殖和分泌活动。
Am J Pathol. 1988 Jan;130(1):193-204.
5
A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma.人类支气管源性癌患者生存率与肿瘤生长动力学的比较。
Br J Cancer. 1988 Oct;58(4):419-22. doi: 10.1038/bjc.1988.233.

本文引用的文献

1
LABELING OF HUMAN TUMORS WITH TRITIATED THYMIDINE.用氚标记胸腺嘧啶核苷标记人类肿瘤
Arch Pathol. 1965 Mar;79:324-8.
2
Autoradiographic studies of in vitro incorporation of uridine and thymidine by human tumor tissue.人体肿瘤组织对尿苷和胸苷体外掺入的放射自显影研究。
Cancer Res. 1962 Oct;22:1113-9.
3
A method of labeling tissues with tritiated thymidine in vitro and its use in comparing rates of cell proliferation in duct epithelium, fibroadenoma, and carcinoma of human breast.一种体外用氚标记胸腺嘧啶核苷标记组织的方法及其在比较人乳腺导管上皮、纤维腺瘤和癌中细胞增殖速率方面的应用。
Cancer. 1961 May-Jun;14:639-43. doi: 10.1002/1097-0142(199005/06)14:3<639::aid-cncr2820140327>3.0.co;2-c.
4
In vitro uptake of tritiated thymidine by carcinoma of the human colon.人结肠癌对氚标记胸腺嘧啶核苷的体外摄取
Cancer Res. 1966 Apr;26(4):733-40.
5
In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical considerations.肿瘤细胞增殖的体外研究。I. 方法的批判性评估及理论思考。
Eur J Cancer (1965). 1965 Nov;1(3):275-9. doi: 10.1016/0014-2964(65)90060-5.
6
Effects of chemotherapy on the incorporation of 3 H-thymidine into DNA of human neoplastic tissue.化疗对3H-胸腺嘧啶核苷掺入人肿瘤组织DNA的影响。
Natl Cancer Inst Monogr. 1971 Dec;34:197-203.
7
Analysis of the cell kinetics of human solid tumors.人类实体瘤细胞动力学分析
Cancer. 1971 Nov;28(5):1100-10. doi: 10.1002/1097-0142(1971)28:5<1100::aid-cncr2820280503>3.0.co;2-1.
8
The kinetics of tumour cell proliferation and radiotherapy.
Br J Radiol. 1971 May;44(521):325-47. doi: 10.1259/0007-1285-44-521-325.
9
The kinetics of cellular proliferation in normal and malignant tissues. II. An in vitro method for incorporation of tritiated thymidine in human tissues.正常组织与恶性组织中细胞增殖的动力学。II. 氚标记胸腺嘧啶核苷掺入人体组织的体外方法。
Radiology. 1969 May;92(6):1309-20. doi: 10.1148/92.6.1309.
10
Correlation of histologic types with cell kinetic studies in lung cancer.肺癌组织学类型与细胞动力学研究的相关性
Cancer Chemother Rep 3. 1973 Mar;4(2):69-71.

人肺肿瘤的体外胸苷标记

In vitro thymidine labelling of human pulmonary neoplasms.

作者信息

Kerr K M, Robertson A M, Lamb D

出版信息

Br J Cancer. 1983 Feb;47(2):245-52. doi: 10.1038/bjc.1983.32.

DOI:10.1038/bjc.1983.32
PMID:6824569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2011269/
Abstract

The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine (5 muCi ml-1) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of labelling was achieved along the edges of fragments and the depth of this rim varied from tumour to tumour. A technique for counting TLIs was therefore devised to take this into account. In general, those tumours showing low TLI values of less than 5.0% showed a greater depth of labelling. The common malignant tumours of the bronchus showed a wide range of values (2.2-30.4%) though the adenocarcinomata had a lower average value than the other groups. With the squamous carcinomata a relationship with differentiation was shown. The mean value for small cell carcinomata (16.9%)--a highly aggressive tumour--was no higher than for the other groups. The low grade malignant tumours showed TLIs of less than 3.0% and these values correlate with their less aggressive clinical behaviour. Labelling of stromal cells and inflammatory cells varied greatly from tumour to tumour; however, no correlation was found with the TLIs of tumour cells.

摘要

采用放射自显影术评估了58例人肺肿瘤的体外胸苷标记指数(TLI)。标记技术包括在3个大气压的高压氧条件下,将1立方毫米的肿瘤碎片与3H-胸苷(5微居里/毫升)一起孵育。仅在碎片边缘形成了一圈标记,且这一圈标记的深度因肿瘤而异。因此设计了一种计算TLI的技术以考虑到这一点。一般来说,那些TLI值低于5.0%的肿瘤显示出更深的标记深度。支气管常见恶性肿瘤显示出广泛的数值范围(2.2 - 30.4%),尽管腺癌的平均值低于其他组。对于鳞状细胞癌,显示出与分化的关系。小细胞癌(一种高度侵袭性肿瘤)的平均值(16.9%)并不高于其他组。低级别恶性肿瘤的TLI低于3.0%,这些数值与其侵袭性较低的临床行为相关。基质细胞和炎性细胞的标记在不同肿瘤之间差异很大;然而,未发现与肿瘤细胞的TLI相关。